Ultrasound probe with smart accessory

Information

  • Patent Grant
  • 12102481
  • Patent Number
    12,102,481
  • Date Filed
    Friday, June 3, 2022
    2 years ago
  • Date Issued
    Tuesday, October 1, 2024
    3 months ago
Abstract
A medical ultrasound system that includes an ultrasound probe and one of number of optional accessories attached to the ultrasound probe. The accessory exchanges data with the probe and receives power from the probe. The accessory includes processors and logic that governs it operation thereby adding functionality to the probe. The accessory receives input and provides output via any of a number of communication mechanisms, i.e., wireless, electrical, optical, RFID, IR, and the like. The accessory adds functionality to the probe, such as fiber optic shape sensing, obtaining electrical signals, obtaining bio-impedance measurements, tracking a needle, and determining the orientation of the probe. The accessory may include a needle guide, a triphalangeal support structure, or an acoustically transparent cap.
Description
BACKGROUND

Obtaining ultrasound images may be employed during a various medical procedures. Ultrasound systems and the associated ultrasound probes may be combined with a wide variety other medical devices and systems to enhance the performance of the medical procedures and reduce patient risk. However, the modification of the ultrasound systems or probes to accommodate integrated use with the other medical devices can be costly and logically complex. Systems and devices disclosed herein address the forgoing.


SUMMARY

Briefly summarized, disclosed herein is an ultrasound system that includes an ultrasound probe and an accessory attached to the ultrasound probe, where data is exchanged between the ultrasound probe and the accessory via a communication interface, and/or where the ultrasound probe supplies electrical power to the accessory via a power interface.


In some embodiments, the accessory is configured to selectively attach to and detach from the ultrasound probe.


In some embodiments, the accessory is coupled with the ultrasound probe across a medical procedural barrier.


In some embodiments, the ultrasound system further includes the medical procedural barrier, where the medical procedural barrier includes a sheath covering the ultrasound probe.


In some embodiments, the power interface includes electrical contacts, a magnetic field configured to transfer electrical power to the accessory, or a combination of the electrical contacts and the magnetic field.


In some embodiments, the communication interface includes a wireless connection between the ultrasound probe and the accessory.


In some embodiments, the wireless connection facilitates obtaining accessory identification data from an RFID chip of the accessory.


In some embodiments, the communication interface includes a fiber optic interface such that data is optically exchanged between the ultrasound probe and the accessory.


In some embodiments, the accessory is configured to obtain input data via a number of accessory devices, where the number of accessory devices includes one or more of: an operator interface including buttons, a joystick, or a scroll wheel; a fingerprint scanner; a microphone; an infrared receiver; an RFID reader; a scanner; or a camera.


In some embodiments, the accessory includes an optical fiber system including an optical fiber having a number of sensors disposed along a length of the optical fiber, and the data includes one or more of: doppler data related to fluid or tissue motion adjacent the optical fiber; an image acquired by the optical fiber; a shape or strain of the optical fiber; a motion of at least a portion of the optical fiber.


In some embodiments, the accessory includes an orientation monitoring system configured to determine an orientation of the ultrasound probe, where the orientation monitoring system includes one or more of an inertial measurement unit (IMU) or a gyroscope, and the data includes an orientation of the ultrasound probe.


In some embodiments, the accessory includes a magnetic tracking system configured to track a location and/or an orientation of a needle, and the data includes the location and/or an orientation of the elongate medical device with respect to the ultrasound probe.


In some embodiments, the accessory includes a bio-impedance system configured to determine an impedance of a substance adjacent an elongate medical device of the impedance system when the elongate medical device is inserted within the patient, and the data includes a determined impedance of the substance.


In some embodiments, the accessory includes an electrical signal monitoring system, where the electrical signal monitoring system includes an electrode disposed at a distal tip of the elongate medical device, where the electrode is configured to electrically couple with a patient when the elongate medical device is inserted within the patient, and where the data includes an electrical signal emanating from the patient.


In some embodiments, the accessory is configured to provide output via one or more of: a number of light indicators; a light projector; an audio transducer; a haptic transducer; a writing to an RFID chip; electrical signals; or fiber optic signals.


In some embodiments, the ultrasound system is configured to (i) identify one or more blood vessels within an ultrasound image and (ii) determine a location of the one or more blood vessels with respect to the ultrasound probe. In such embodiments, the ultrasound system includes the one or more light indicators and the one or more light indicators are configured to indicate the location of the one or more blood vessels.


In some embodiments, the ultrasound system is configured to (i) identify one or more blood vessels within an ultrasound image and (ii) determine a location of the one or more blood vessels with respect to the ultrasound probe. In such embodiments, the ultrasound system includes the projected light, where the projected light includes an indicium projected onto the patient, that indicates an insertion site for a needle.


In some embodiments, the accessory further includes one or more of: a needle guide; a triphalangeal support structure; a medical procedural barrier control mechanism; or an acoustically transparent cap.


In some embodiments, the accessory includes an output portal configured to provide data and/or power to an external device, where the output portal includes one or more of an electrical interface, a magnetic field interface, or an optical interface.


Also disclosed herein is an ultrasound probe accessory that, according to some embodiments, includes an accessory housing configured for selective attachment to and detachment from an ultrasound probe, and a console disposed within the housing. The console includes one or more processors and a non-transitory computer-readable storage medium having logic stored thereon that when executed by the one or more processors governs operation of the accessory to enhance functionality of the ultrasound probe. In such embodiments, the accessory is configured to receive electrical power from the ultrasound probe and/or exchange data with the ultrasound probe.


These and other features of embodiments of the present invention will become more fully apparent from the following description and appended claims, or may be learned by the practice of embodiments of the invention as set forth hereinafter.





BRIEF DESCRIPTION OF THE DRAWINGS

A more particular description of the present disclosure will be rendered by reference to specific embodiments thereof that are illustrated in the appended drawings. It is appreciated that these drawings depict only typical embodiments of the invention and are therefore not to be considered limiting of its scope. Example embodiments of the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:



FIG. 1 is an illustration of an ultrasound imaging system including an accessory in use with a patient, in accordance with some embodiments;



FIG. 2A is an illustration of an ultrasound probe of FIG. 1 with an attached accessory having a number of light indicators, in accordance with some embodiments;



FIG. 2B is an illustration of the ultrasound probe of FIG. 1 with an attached accessory having a light projector, in accordance with some embodiments;



FIG. 3A is an illustration of an accessory including an electrical signal monitoring system, in accordance with some embodiments;



FIG. 3B is an illustration of an accessory including a fiber optic system, in accordance with some embodiments;



FIG. 3C is an illustration of an accessory including a bio-impedance system, in accordance with some embodiments;



FIG. 3D is an illustration of an accessory including a probe orientation monitoring system, in accordance with some embodiments;



FIG. 3E is an illustration of an accessory including a needle tracking system, in accordance with some embodiments;



FIG. 4A is an illustration of an accessory including a needle guide, in accordance with some embodiments;



FIG. 4B is an illustration of an accessory including a triphalangeal support structure, in accordance with some embodiments; and



FIG. 4C is an illustration of an accessory including an acoustically transparent cap, in accordance with some embodiments.





DETAILED DESCRIPTION

Reference will now be made to figures wherein like structures will be provided with like reference designations. It is understood that the drawings are diagrammatic and schematic representations of exemplary embodiments of the present invention, and are neither limiting nor necessarily drawn to scale.


For clarity it is to be understood that the word “proximal” refers to a direction relatively closer to a clinician using the device to be described herein, while the word “distal” refers to a direction relatively further from the clinician. For example, the end of a needle or catheter placed within the body of a patient is considered a distal end of the needle or catheter, while the needle or catheter end remaining outside the body is a proximal end of the needle or catheter. Also, the words “including,” “has,” and “having,” as used herein, including the claims, shall have the same meaning as the word “comprising.”


The phrases “connected to,” or “coupled with,” and “in communication with” refer to any form of interaction between two or more entities, including but not limited to mechanical, electrical, magnetic, electromagnetic, fluid, wireless, and optical interaction. Two components may be physically coupled with each other even though they are not in direct contact with each other. For example, two components may be physically coupled with each other through an intermediate component.


The term “logic” may be representative of hardware, firmware or software that is configured to perform one or more functions. As hardware, the term logic may refer to or include circuitry having data processing and/or storage functionality. Examples of such circuitry may include, but are not limited or restricted to a hardware processor (e.g., microprocessor, one or more processor cores, a digital signal processor, a programmable gate array, a microcontroller, an application specific integrated circuit “ASIC”, etc.), a semiconductor memory, or combinatorial elements.


Additionally, or in the alternative, the term logic may refer to or include software such as one or more processes, one or more instances, Application Programming Interface(s) (API), subroutine(s), function(s), applet(s), servlet(s), routine(s), source code, object code, shared library/dynamic link library (dll), or even one or more instructions. This software may be stored in any type of a suitable non-transitory storage medium, or transitory storage medium (e.g., electrical, optical, acoustical or other form of propagated signals such as carrier waves, infrared signals, or digital signals). Examples of a non-transitory storage medium may include, but are not limited or restricted to a programmable circuit; non-persistent storage such as volatile memory (e.g., any type of random access memory “RAM”); or persistent storage such as non-volatile memory (e.g., read-only memory “ROM”, power-backed RAM, flash memory, phase-change memory, etc.), a solid-state drive, hard disk drive, an optical disc drive, or a portable memory device. As firmware, the logic may be stored in persistent storage.



FIG. 1 illustrates an ultrasound imaging system (system) 100 in use with a patient 50. The system 100 is generally configured for ultrasonically imaging a target area of the patient 50. The system 100 may be configured to facilitate the placement of a medical device (e.g., a guidewire, a catheter, a needle, or the like) within a patient vasculature. In some embodiments, the system 100 may be configured to facilitate defining a vascular access pathway for the medical device, such as via the insertion of a needle, for example. In some embodiments, the system 100 may further facilitate the positioning and/or orienting of the needle so that the needle may be accurately inserted into a target blood vessel.


The system 100 generally includes a display module 110, an ultrasound probe (probe) 120, and a console 115. The display module 110 includes a display 111. The display 111 and the probe 120 each include one or more user input controls 112, 122, respectively. The console 115 includes a number of console components (not shown) that govern the operation of the system 100. The console components may include inter alia one or more processors and memory (e.g., non-volatile memory or non-transitory, computer-readable storage medium) having logic stored thereon. Any portion of the console 115 may be included in the display module 110 and/or the probe 120. Briefly, the probe 120 is configured to (i) transmit ultrasonic signals from a head portion 121 thereof into a portion of a patient body 50 and (ii) receive the ultrasonic signals after reflection by internal structures of the patient body. The system 100 processes the reflected ultrasonic signals for depiction on the display 111. The system 100 may also be configured to (i) identify one or more blood vessels 52 within an ultrasound image 113 and (ii) determine a location of the one or more blood vessels 52 with respect to the probe 120.


The system 100 further includes an accessory 150 coupled with the probe 120. The accessory 150 includes a housing 155 configured to selectively attach to and detach from the probe 120. The accessory 150 is a smart device, i.e., the accessory 150 includes a console 156 disposed within the housing 155 that may include one or more processors, and memory (e.g., non-transitory computer-readable storage medium) having logic stored thereon that governs the operation of the accessory 150. The accessory 150 is one of a number (e.g., 2, 3, 4, 5, 6 or more) of optional accessories that may be coupled with the probe 120 and configured to enhance functionality of the probe 120 or the system 100 as a whole.


The accessory 150 may be configured to exchange data with the probe 120 via a communication interface 130. The communication interface 130 may include a number of a communication mechanisms either individually or in combination between the accessory 150 and the probe 120. The communication mechanisms may include an electrical connection, a fiber optical coupling, an inductive (or magnetic field) coupling, or a wireless connection. Exemplary wireless communication modalities can include WiFi, Bluetooth, Near Field Communications (NFC), cellular Global System for Mobile Communication (“GSM”), electromagnetic (EM), radio frequency (RF), combinations thereof, or the like. The data may include any information related to the operation of the accessory 150. The data may also include identification data of the accessory 150, such as a name, a model, a serial number, and/or manufacturing date, for example.


In some embodiments, the accessory 150 may be configured to only transmit data to the probe 120, and in some embodiments the accessory 150 may be configured to only receive data from the probe 120. In further embodiments, the accessory 150 may be configured to neither transmit data to the probe 120 nor receive data from the probe 120.


In some embodiments, the probe 120 may include a radio frequency identification (RFID) reader 123 configured to obtain information from the accessory 150 including an identification of the accessory 150. As discussed above, the accessory 150 may be one of a number of accessories and a such each accessory may include a unique identification. By way of example, in use, the RFID reader 123 may obtain the unique identification of the accessory 150 from an RFID chip of the accessory.


The accessory 150 may receive electrical power from the probe 120 via a power interface 131. The power interface 131 may include an electrical connection, or an inductive (or magnetic field) coupling. In some embodiments, the accessory 150 may include a power source (e.g., battery) to augment the electrical power received from the probe 120. In some embodiments, the accessory 150 may include a power source (e.g., battery) as an alternative to receiving electrical power from the probe 120, and as such, the accessory 150 may be configured to not receive electrical power from the probe 120.


In some embodiments, the accessory 150 is coupled with the probe 120 across a medical procedural barrier 124 to define a sterile barrier between the probe 120 and the patient. In some embodiments, the medical procedural barrier 124 includes a sheath that covers the probe 120. As such, the communication interface 130 and the power interface 131 are configured to operate across the medical procedural barrier 124. In some embodiments, the system 100 may include the medical procedural barrier 124.


In some embodiments, the system 100 may include a barrier control mechanism 153. The barrier control mechanism 153 may be configured to isolate or control a portion of the medical procedural barrier 124 disposed between the probe 120 and the accessory 150 so that an electrical connection may breach the medical procedural barrier 124 while maintaining the functionality of the medical procedural barrier 124. Defining the electrical connection may include piercing the medical procedural barrier 124 with one or more electrical pins of blades (not shown).


In some embodiments, the accessory 150 includes an output portal 132 configured to provide data and/or power to an external device. The output portal 132 may include an electrical connection interface to enable to the accessory 150 to electrically provide the data and/or the power to the external device. Alternatively, or in addition to the electrical connection interface, the output portal 132 may include an inductive (or magnetic field) interface to provide the data and/or the power to the external device. The output portal 132 may also include an optical interface to optically provide the data to the external device.


The accessory 150 may be configured to obtain input data via one or more of a number of optional accessory input devices 151. The input devices 151 may include an operator interface having buttons, a joystick, or a scroll wheel for manually inputting data, or adjusting settings of the accessory 150. The input devices 151 may include a fingerprint scanner to obtain an identification of a clinician or the patient 50. The input devices 151 may include a microphone to obtain and/or record audio information, where the audio information may include clinician or patient speech, audio output (e.g., alarms) of other medical equipment, or any other audible sounds during use of the system 100. The input devices 151 may include an infrared (IR) receiver for receiving input via an IR or near IR connection.


The input devices 151 may include an RFID reader; a scanner; and/or camera for obtaining and/or logging data from any suitable source, such as separate medical device, a medical fluid container, a clinician ID badge, or a patient ID bracelet, for example.


The accessory 150 may be configured to provide output, such as output data to the clinician. The output may be provided via one or more output devices 152, such as an audio transducer and/or a haptic transducer. The output may also be provided via data writings to the RFID chip, electrical signals, or fiber optic signals. In some embodiments, the accessory 150 may include the audio transducer to sound an alarm or other audible notification. For example, the accessory 150 may provide an event notification via the audio transducer for various events during a procedure, such as a cannulation of the target blood vessel, a vein/artery confirmation, or a deviation of a needle from vasculature access pathway, for example. Similarly, as the probe 120 is hand-held, the accessory 150 may cause a vibration of the probe 120 via the haptic transducer in response to various procedural events. In some embodiments, the accessory 150 may generate a data packet of procedural events and send the data packet to the probe 120 via the communication interface 130 or to an external device via the output portal 132.



FIGS. 2A-4C illustrates various accessory embodiments. It is noted that any subset of the accessory embodiments of FIGS. 2A-4C may be combined to define additional accessory embodiments.



FIG. 2A illustrates an accessory 250 attached to the probe 120, where the accessory 250 may in some respects resemble the components and functionality of the accessory 150. The accessory 250 includes a number of light indicators 210 arranged to indicate a location in relation to the probe 120. The location may include center location of the probe 120 or location of a target blood vessel such as the vein 252 in with respect to the probe 120, for example. In some embodiments, the light indicators 210 may be configured indicate a target blood vessel, such as the vein 252 in accordance with image data received from the probe 120. Still in other embodiments, the light indicators 210 may be configured differentiate one blood vessel from another blood vessel. For example, the light indicators 210 may be configured differentiate the vein 252 from an artery 253. In some embodiments, the accessory 250 may be configured to not transmit data to the probe 120.



FIG. 2B illustrates an accessory 260 attached to the probe 120, where the accessory 260 may in some respects resemble the components and functionality of the accessory 150. The accessory 260 includes a light projector 220 configured to display images, shapes, indicia, colors, or the like onto the skin surface 51 of the patient 50. For example, the light projector 220 may project an indicium 221 on the skin surface 51 of the patient 50 indicating a calculated (or otherwise determined) insertion site 221 for the target blood vessel 254 in accordance with image data received from the probe 120. Similar to the light indicators 210, the light projector 220 may be configured to differentiate one blood vessel from another blood vessel. For example, the light projector 220 may be configured differentiate a vein from an artery. In some embodiments, the light projector 220 may project an indicium, such as an “A”, for example, adjacent an artery and a “V” adjacent a vein. The light projector 220 may indicate an artery versus a vein in other ways, such as projecting a color over a projected image of the blood vessel. As may be appreciated by one of ordinary skill, many other suitable ways of differentiating a vein from an artery or otherwise identifying a blood vessel via the projector 220 may be employed, which other suitable ways are disclosed herein. In some embodiments, the accessory 260 may be configured to not transmit data to the probe 120.



FIG. 3A illustrates a distal portion of the probe 120 having the accessory 350 attached thereto, where the accessory 350 may in some respects resemble the components and functionality of the accessory 150. The accessory 350 includes an electrical signal monitoring system 310 that includes an elongate medical device 311 configured for advancement along a vasculature 301 of the patient, such as the superior vena cava 303 entering the heart 307 of the patient, for example. The elongate medical device 311 includes an electrode 312 at a distal end 311A, where the electrode 312 is configured to obtain an electrical signal from the patient 50 such as an electro-cardiogram (ECG) signal, for example. As such, the system 100 may be configured to obtain an ECG signal or any other electrical signal emanating from or otherwise present within the patient.



FIG. 3B illustrates a distal portion of the probe 120 having the accessory 360 attached thereto, where the accessory 360 may in some respects resemble the components and functionality of the accessory 150. The accessory 360 includes a fiber optic system 320 that includes a multi-core optical fiber 321 having a number of sensors (e.g., Fiber Bragg Gratings) 322 disposed along the optical fiber 321. The optical fiber 321 may be configured for advancement along a blood vessel 302 of the patient 50 so that the fiber optic system 320 may acquire data related to the blood vessel 302. In some embodiments, fiber optic system 320 may determine a fluid (e.g., blood 305) or tissue motion adjacent the optical fiber 321 via the doppler effect. The fiber optic system 320 may further acquire data related to a strain, a shape, or a motion of at least a portion of the optical fiber 321 when the optical fiber 321 is advanced along the blood vessel 302. The fiber optic system 320 may also obtain images via the optical fiber 321, such as an image of an interior of a blood vessel, for example. During use, the fiber optic system 320 may provide data to the system 100 related to blood flow, shape or strain of the optical fiber 321, a motion of the optical fiber 321, and/or an image obtained by the optical fiber 321.



FIG. 3C illustrates a distal portion of the probe 120 having the accessory 370 attached thereto, where the accessory 370 may in some respects resemble the components and functionality of the accessory 150. The accessory 370 includes an impedance system 330 having an elongate medical device 331 (e.g., a catheter, a guidewire, a needle, or a stylet) that may be inserted into the patient, such as advancement along a blood vessel 302, for example. The elongate medical device 331 includes two or more electrodes 332 distributed along the elongate medical device 331. The two or more electrodes 332 are configured to obtain an electrical impedance of a bodily substance, such as the blood 305 within the blood vessel 302, for example. In some embodiments, the elongate medical device 331 may be configured for insertion into body tissue so that the two or more electrodes 332 may obtain an electrical bio-impedance of the tissue. During use, the impedance system 330 may provide bio-impedance data to the system 100.



FIG. 3D illustrates a distal portion of the probe 120 having the accessory 380 attached thereto, where the accessory 380 may in some respects resemble the components and functionality of the accessory 150. The accessory 380 includes a probe orientation monitoring system 340. The probe orientation monitoring system 340 includes a gyroscope and/or an inertia measurement unit (IMU) 341 to determine the orientation and/or position of the probe 120. In some instances, the clinician may reposition the probe 120 during a procedure. As such, the probe orientation monitoring system 340 is configured to monitor and determine the orientation and/or position of the probe 120. In some embodiments, the probe orientation monitoring system 340 may determine the orientation/position or a shift in the orientation/position of the probe 120 during use. The accessory 380 may further provide data to the system 100 pertaining to the orientation/position or a shift in the orientation/position of the probe 120.



FIG. 3E illustrates a distal portion of the probe 120 having the accessory 390 attached thereto, where the accessory 390 may in some respects resemble the components and functionality of the accessory 150. The accessory 390 includes a needle tracking system 391 configured to track (e.g., magnetically track) the orientation and/or position of a needle 392 with respect to the probe 120 during use. In some embodiments, the needle 392 may include a number of magnetic elements 393 and the needle tracking system 391 may include a number of magnetic sensors 394. A Medical device tracking and guidance system is described for various instruments, including needles, in U.S. Pat. No. 9,521,961 titled “Systems and Methods for Guiding a Medical Instrument” filed on Dec. 23, 2011, which is included herein by reference in its entirety. The needle tracking system 391 provides needle tracking data to the system 100.



FIG. 4A illustrates the accessory 450, where the accessory 390 may in some respects resemble the components and functionality of the accessory 150. The accessory 450 includes a needle guide 410 attached thereto. The needle guide 410 includes a channel 411 configured for receiving a needle 412 therein such that the needle guide 410 defines a lateral position and an orientation of the needle 412 with respect to the accessory 450 (i.e., the probe 120) during use. In some embodiments, the accessory 450 may alternatively include a needle guide connector (not shown) configured for selective attachment to and detachment from the needle guide 410. As the accessory 450 may be a passive device, the accessory 450 may be configured to neither exchange data with nor receive electrical power from the probe 120.



FIG. 4B illustrates an accessory 460 that may in some respects resemble the components and functionality of the accessory 150. The accessory 460 includes triphalangeal stabilization structure 420 (e.g., a tripod structure) having three support members (legs) 421-423 extending between the accessory 450 and the skin surface 51 of the patient 50. The triphalangeal stabilization structure 420 is configured to enhance the stabilization of the probe 120 when the probe 120 is placed on the patient. As the accessory 460 may be a passive device, the accessory 460 may be configured to neither exchange data with nor receive electrical power from the probe 120.



FIG. 4C illustrates an accessory 470 that may in some respects resemble the components and functionality of the accessory 150. The accessory 470 includes a lens cap 430 configured for disposition between the probe 120 and the skin surface 51, where the lens portion 430A of the lens cap 430 is ultrasonically transparent. In some embodiments, the lens cap 430 includes a gel 431 to enhance an ultrasonic coupling of the probe 120 with the skin surface 51. As the accessory 470 may be a passive device, the accessory 470 may be configured to neither exchange data with nor receive electrical power from the probe 120.


Embodiments of the invention may be embodied in other specific forms without departing from the spirit of the present disclosure. The described embodiments are to be considered in all respects only as illustrative, not restrictive. The scope of the embodiments is, therefore, indicated by the appended claims rather than by the foregoing description. All changes that come within the meaning and range of equivalency of the claims are to be embraced within their scope.

Claims
  • 1. A medical ultrasound system, comprising: an ultrasound probe; and an accessory attached to the ultrasound probe, wherein the medical ultrasound system is configured for one or both of: exchanging data between the ultrasound probe and the accessory via a communication interface, the communication interface that includes a fiber-optical coupling mechanism such that the data can be optically exchanged between the ultrasound probe and the accessory, and supplying electrical power from the ultrasound probe to the accessory via a power interface, wherein the accessory is coupled with the ultrasound probe across a medical procedural barrier, the medical procedural barrier disposed adjacent the ultrasound probe, wherein the accessory includes a fiber optic system including an optical fiber having a number of sensors disposed along a length of the optical fiber, and the data includes one or more of: doppler data related to fluid or tissue motion adjacent the optical fiber; an image acquired by the optical fiber; a shape or strain of the optical fiber; or a motion of the optical fiber, and wherein the optical fiber is configured for advancement along a blood vessel.
  • 2. The ultrasound system of claim 1, wherein the accessory is configured to selectively attach to and detach from the ultrasound probe.
  • 3. The ultrasound system of claim 1, further comprising the medical procedural barrier, the medical procedural barrier including a sheath covering the ultrasound probe.
  • 4. The ultrasound system of claim 1, wherein the power interface includes electrical contacts and/or a magnetic field configured to transfer the electrical power to the accessory.
  • 5. The ultrasound system of claim 1, wherein the communication interface includes a wireless connection between the ultrasound probe and the accessory.
  • 6. The ultrasound system of claim 5, wherein the wireless connection facilitates obtaining accessory identification data from an RFID chip of the accessory.
  • 7. The ultrasound system of claim 1, wherein the accessory is configured to obtain input data via a number of accessory input devices that include one or more of: an operator interface including buttons, a joystick, or a scroll wheel;a fingerprint scanner;a microphone;an IR receiver;an RFID reader;a scanner; ora camera.
  • 8. The ultrasound system of claim 1, wherein: the accessory includes an orientation monitoring system configured to determine an orientation of the ultrasound probe, the orientation monitoring system includes one or more of an inertial measurement unit (IMU) or a gyroscope, and the data includes the orientation of the ultrasound probe.
  • 9. The ultrasound system of claim 1, wherein: the accessory includes a magnetic tracking system configured to track one or more of: a location or an orientation of a needle, and the data includes one or more of: the location or the orientation of the needle with respect to the ultrasound probe.
  • 10. The ultrasound system of claim 1, wherein: the accessory includes a bio-impedance system configured to determine an impedance of a substance adjacent an elongate medical device of the bio-impedance system when the elongate medical device is inserted within a patient, and the data includes the determined impedance of the substance.
  • 11. The ultrasound system of claim 1, wherein: the accessory includes an electrical signal monitoring system, the electrical signal monitoring system includes an electrode disposed at a distal tip of an elongate medical device, the electrode is configured to electrically couple with a patient when the elongate medical device is inserted within the patient, and the data includes an electrical signal emanating from the patient.
  • 12. The ultrasound system of claim 1, wherein the accessory is configured to provide output via one or more of: a number of light indicators;a light projector;an audio transducer;a haptic transducer;a writing to an RFID chip;electrical signals; orfiber optic signals.
  • 13. The ultrasound system of claim 1, wherein: the ultrasound system is configured to identify one or more blood vessels within an ultrasound image,the ultrasound system is configured to determine a location of the one or more blood vessels with respect to the ultrasound probe,the ultrasound system includes one or more light indicators, andthe one or more light indicators are configured to indicate the location of the one or more blood vessels with respect to the ultrasound probe.
  • 14. The ultrasound system of claim 1, wherein: the ultrasound system is configured to identify a target blood vessel within an ultrasound image, the ultrasound system is configured to determine a location of the target blood vessel with respect to the ultrasound probe, the ultrasound system includes a light projector, and a light from the light projector includes an indicium projected onto a patient, the indicium indicating an insertion site for a needle to access the target blood vessel.
  • 15. The ultrasound system of claim 1, wherein the accessory further includes one or more of: a needle guide,a triphalangeal support structure,a medical procedural barrier control mechanism; oran acoustically transparent cap.
  • 16. The ultrasound system of claim 1, wherein the accessory further includes an output portal configured to provide data and/or power to an external device, the output portal including one or more of an electrical interface, a magnetic field interface, or an optical interface.
  • 17. An ultrasound probe accessory, comprising: an accessory housing configured for selective attachment to and detachment from an ultrasound probe; a console disposed within the accessory housing, the console including one or more processors and non-transitory computer-readable storage medium having logic stored thereon that when executed by the one or more processors governs operation of the ultrasound probe accessory to enhance functionality of the ultrasound probe; and a communication interface including a fiber-optical coupling mechanism such that data can be optically exchanged between the ultrasound probe and the ultrasound probe accessory, wherein the ultrasound probe accessory is configured for one or both of: receiving electrical power from the ultrasound probe, and exchanging data with the ultrasound probe, wherein the ultrasound probe accessory is configured to couple with the ultrasound probe across a medical procedural barrier with the medical procedural barrier disposed adjacent the ultrasound probe, wherein the ultrasound probe accessory includes a fiber optic system including an optical fiber having a number of sensors disposed along a length of the optical fiber, and the data includes one or more of: doppler data related to fluid or tissue motion adjacent the optical fiber; an image acquired by the optical fiber; a shape or strain of the optical fiber; or a motion of the optical fiber, and wherein the optical fiber is configured for advancement along a blood vessel.
US Referenced Citations (320)
Number Name Date Kind
5148809 Biegeleisen-Knight et al. Sep 1992 A
5181513 Touboul et al. Jan 1993 A
5325293 Dorne Jun 1994 A
5441052 Miyajima Aug 1995 A
5549554 Miraki Aug 1996 A
5573529 Haak et al. Nov 1996 A
5775322 Silverstein et al. Jul 1998 A
5879297 Haynor et al. Mar 1999 A
5908387 LeFree et al. Jun 1999 A
5967984 Chu et al. Oct 1999 A
5970119 Hofmann Oct 1999 A
6004270 Urbano et al. Dec 1999 A
6019724 Gronningsaeter et al. Feb 2000 A
6068599 Saito et al. May 2000 A
6074367 Hubbell Jun 2000 A
6129668 Haynor et al. Oct 2000 A
6132379 Patacsil et al. Oct 2000 A
6216028 Haynor et al. Apr 2001 B1
6233476 Strommer et al. May 2001 B1
6245018 Lee Jun 2001 B1
6263230 Haynor et al. Jul 2001 B1
6375615 Flaherty et al. Apr 2002 B1
6436043 Bonnefous Aug 2002 B2
6498942 Esenaliev et al. Dec 2002 B1
6503205 Manor et al. Jan 2003 B2
6508769 Bonnefous Jan 2003 B2
6511458 Milo et al. Jan 2003 B2
6524249 Moehring et al. Feb 2003 B2
6543642 Milliorn Apr 2003 B1
6554771 Buil et al. Apr 2003 B1
6592520 Peszynski et al. Jul 2003 B1
6592565 Twardowski Jul 2003 B2
6601705 Molina et al. Aug 2003 B2
6612992 Hossack et al. Sep 2003 B1
6613002 Clark et al. Sep 2003 B1
6623431 Sakuma et al. Sep 2003 B1
6641538 Nakaya et al. Nov 2003 B2
6647135 Bonnefous Nov 2003 B2
6687386 Ito et al. Feb 2004 B1
6749569 Pellegretti Jun 2004 B1
6754608 Svanerudh et al. Jun 2004 B2
6755789 Stringer et al. Jun 2004 B2
6840379 Franks-Farah et al. Jan 2005 B2
6857196 Dalrymple Feb 2005 B2
6979294 Selzer et al. Dec 2005 B1
7074187 Selzer et al. Jul 2006 B2
7244234 Ridley et al. Jul 2007 B2
7359554 Klingensmith et al. Apr 2008 B2
7534209 Abend et al. May 2009 B2
7599730 Hunter et al. Oct 2009 B2
7637870 Flaherty et al. Dec 2009 B2
7681579 Schwartz Mar 2010 B2
7691061 Hirota Apr 2010 B2
7699779 Sasaki et al. Apr 2010 B2
7720520 Willis May 2010 B2
7727153 Fritz et al. Jun 2010 B2
7734326 Pedain et al. Jun 2010 B2
7831449 Ying et al. Nov 2010 B2
7905837 Suzuki Mar 2011 B2
7925327 Weese Apr 2011 B2
7927278 Selzer et al. Apr 2011 B2
8014848 Birkenbach et al. Sep 2011 B2
8050523 Younge et al. Nov 2011 B2
8060181 Rodriguez Ponce et al. Nov 2011 B2
8068581 Boese et al. Nov 2011 B2
8075488 Burton Dec 2011 B2
8090427 Eck et al. Jan 2012 B2
8105239 Specht Jan 2012 B2
8172754 Watanabe et al. May 2012 B2
8175368 Sathyanarayana May 2012 B2
8200313 Rambod et al. Jun 2012 B1
8211023 Swan et al. Jul 2012 B2
8228347 Beasley et al. Jul 2012 B2
8298147 Huennekens et al. Oct 2012 B2
8303505 Webler et al. Nov 2012 B2
8323202 Roschak et al. Dec 2012 B2
8328727 Miele et al. Dec 2012 B2
8388541 Messerly et al. Mar 2013 B2
8409103 Grunwald et al. Apr 2013 B2
8449465 Nair et al. May 2013 B2
8553954 Saikia Oct 2013 B2
8556815 Pelissier et al. Oct 2013 B2
8585600 Liu et al. Nov 2013 B2
8622913 Dentinger et al. Jan 2014 B2
8706457 Hart et al. Apr 2014 B2
8727988 Flaherty et al. May 2014 B2
8734357 Taylor May 2014 B2
8744211 Owen Jun 2014 B2
8754865 Merritt et al. Jun 2014 B2
8764663 Smok et al. Jul 2014 B2
8781194 Malek et al. Jul 2014 B2
8781555 Burnside et al. Jul 2014 B2
8790263 Randall et al. Jul 2014 B2
8849382 Cox et al. Sep 2014 B2
8939908 Suzuki et al. Jan 2015 B2
8961420 Zhang Feb 2015 B2
9022940 Meier May 2015 B2
9138290 Hadjicostis Sep 2015 B2
9155517 Dunbar et al. Oct 2015 B2
9204858 Pelissier et al. Dec 2015 B2
9220477 Urabe et al. Dec 2015 B2
9257220 Nicholls et al. Feb 2016 B2
9295447 Shah Mar 2016 B2
9320493 Visveshwara Apr 2016 B2
9357980 Toji et al. Jun 2016 B2
9364171 Harris et al. Jun 2016 B2
9427207 Sheldon et al. Aug 2016 B2
9445780 Hossack et al. Sep 2016 B2
9456766 Cox et al. Oct 2016 B2
9456804 Tamada Oct 2016 B2
9459087 Dunbar et al. Oct 2016 B2
9468413 Hall et al. Oct 2016 B2
9492097 Wilkes et al. Nov 2016 B2
9521961 Silverstein et al. Dec 2016 B2
9554716 Burnside et al. Jan 2017 B2
9582876 Specht Feb 2017 B2
9597008 Henkel et al. Mar 2017 B2
9610061 Ebbini et al. Apr 2017 B2
9636031 Cox May 2017 B2
9649037 Lowe et al. May 2017 B2
9649048 Cox et al. May 2017 B2
9702969 Hope Simpson et al. Jul 2017 B2
9715757 Ng et al. Jul 2017 B2
9717415 Cohen et al. Aug 2017 B2
9731066 Liu et al. Aug 2017 B2
9814433 Benishti et al. Nov 2017 B2
9814531 Yagi et al. Nov 2017 B2
9861337 Patwardhan et al. Jan 2018 B2
9895138 Sasaki Feb 2018 B2
9913605 Harris et al. Mar 2018 B2
9949720 Southard et al. Apr 2018 B2
10043272 Forzoni et al. Aug 2018 B2
10380919 Savitsky et al. Aug 2019 B2
10380920 Savitsky et al. Aug 2019 B2
10424225 Nataneli et al. Sep 2019 B2
10434278 Dunbar et al. Oct 2019 B2
10449330 Newman et al. Oct 2019 B2
10524691 Newman et al. Jan 2020 B2
10674935 Henkel et al. Jun 2020 B2
10751509 Misener Aug 2020 B2
10758155 Henkel et al. Sep 2020 B2
10765343 Henkel et al. Sep 2020 B2
10896628 Savitsky et al. Jan 2021 B2
11062624 Savitsky et al. Jul 2021 B2
11120709 Savitsky et al. Sep 2021 B2
11311269 Dunbar et al. Apr 2022 B2
11315439 Savitsky et al. Apr 2022 B2
11600201 Savitsky Mar 2023 B1
20020038088 Imran et al. Mar 2002 A1
20020148277 Umeda Oct 2002 A1
20030047126 Tomaschko Mar 2003 A1
20030060714 Henderson et al. Mar 2003 A1
20030073900 Senarith et al. Apr 2003 A1
20030093001 Martikainen May 2003 A1
20030106825 Molina et al. Jun 2003 A1
20030120154 Sauer et al. Jun 2003 A1
20040055925 Franks-Farah et al. Mar 2004 A1
20050000975 Carco et al. Jan 2005 A1
20050049504 Lo et al. Mar 2005 A1
20050165299 Kressy et al. Jul 2005 A1
20050251030 Azar et al. Nov 2005 A1
20050267365 Sokulin et al. Dec 2005 A1
20060013523 Childlers et al. Jan 2006 A1
20060015039 Cassidy et al. Jan 2006 A1
20060020204 Serra et al. Jan 2006 A1
20060079781 Germond-Rouet et al. Apr 2006 A1
20060184029 Haim et al. Aug 2006 A1
20060210130 Germond-Rouet et al. Sep 2006 A1
20070043341 Anderson et al. Feb 2007 A1
20070049822 Bunce et al. Mar 2007 A1
20070073155 Park et al. Mar 2007 A1
20070199848 Ellswood et al. Aug 2007 A1
20070239120 Brock et al. Oct 2007 A1
20070249911 Simon Oct 2007 A1
20080021322 Stone et al. Jan 2008 A1
20080033293 Beasley et al. Feb 2008 A1
20080033759 Finlay Feb 2008 A1
20080051657 Rold Feb 2008 A1
20080146915 McMorrow Jun 2008 A1
20080177186 Slater et al. Jul 2008 A1
20080221425 Olson et al. Sep 2008 A1
20080294037 Richter Nov 2008 A1
20080300491 Bonde et al. Dec 2008 A1
20090012399 Sunagawa et al. Jan 2009 A1
20090143672 Harms et al. Jun 2009 A1
20090143684 Cermak et al. Jun 2009 A1
20090156926 Messerly et al. Jun 2009 A1
20090306509 Pedersen et al. Dec 2009 A1
20100020926 Boese et al. Jan 2010 A1
20100106015 Norris Apr 2010 A1
20100179428 Pedersen et al. Jul 2010 A1
20100211026 Sheetz et al. Aug 2010 A2
20100277305 Garner Nov 2010 A1
20100286515 Gravenstein et al. Nov 2010 A1
20100312121 Guan Dec 2010 A1
20110002518 Ziv-Ari et al. Jan 2011 A1
20110071404 Schmitt et al. Mar 2011 A1
20110295108 Cox Dec 2011 A1
20110313293 Lindekugel et al. Dec 2011 A1
20120179038 Meurer et al. Jul 2012 A1
20120197132 O'Connor Aug 2012 A1
20120209121 Boudier Aug 2012 A1
20120220865 Brown et al. Aug 2012 A1
20120238875 Savitsky et al. Sep 2012 A1
20120277576 Lui Nov 2012 A1
20130041250 Pelissier et al. Feb 2013 A1
20130102889 Southard et al. Apr 2013 A1
20130131499 Chan et al. May 2013 A1
20130131502 Blaivas et al. May 2013 A1
20130150724 Blaivas et al. Jun 2013 A1
20130188832 Ma et al. Jul 2013 A1
20130218024 Boctor et al. Aug 2013 A1
20130324840 Zhongping et al. Dec 2013 A1
20140005530 Liu et al. Jan 2014 A1
20140031690 Toji et al. Jan 2014 A1
20140036091 Zalev et al. Feb 2014 A1
20140073976 Fonte et al. Mar 2014 A1
20140100440 Cheline et al. Apr 2014 A1
20140155737 Manzke Jun 2014 A1
20140180098 Flaherty et al. Jun 2014 A1
20140188133 Misener Jul 2014 A1
20140188440 Donhowe et al. Jul 2014 A1
20140276059 Sheehan Sep 2014 A1
20140276081 Tegels Sep 2014 A1
20140276085 Miller Sep 2014 A1
20140276690 Grace Sep 2014 A1
20140343431 Vajinepalli et al. Nov 2014 A1
20150005738 Blacker Jan 2015 A1
20150011887 Ahn et al. Jan 2015 A1
20150065916 Maguire et al. Mar 2015 A1
20150073279 Cai et al. Mar 2015 A1
20150112200 Oberg et al. Apr 2015 A1
20150209113 Burkholz et al. Jul 2015 A1
20150209526 Matsubara et al. Jul 2015 A1
20150294497 Ng et al. Oct 2015 A1
20150297097 Matsubara et al. Oct 2015 A1
20150327841 Banjanin et al. Nov 2015 A1
20150359991 Dunbar et al. Dec 2015 A1
20160029995 Navratil et al. Feb 2016 A1
20160100970 Brister et al. Apr 2016 A1
20160101263 Blumenkranz et al. Apr 2016 A1
20160113699 Sverdlik et al. Apr 2016 A1
20160120607 Sorotzkin et al. May 2016 A1
20160143622 Xie et al. May 2016 A1
20160166232 Merritt Jun 2016 A1
20160202053 Walker et al. Jul 2016 A1
20160213398 Liu Jul 2016 A1
20160278743 Kawashima Sep 2016 A1
20160278869 Grunwald Sep 2016 A1
20160296208 Sethuraman et al. Oct 2016 A1
20160374644 Mauldin, Jr. et al. Dec 2016 A1
20170079548 Silverstein et al. Mar 2017 A1
20170086785 Bjaerum Mar 2017 A1
20170164923 Matsumoto Jun 2017 A1
20170172424 Eggers et al. Jun 2017 A1
20170188839 Tashiro Jul 2017 A1
20170196535 Arai et al. Jul 2017 A1
20170215842 Ryu et al. Aug 2017 A1
20170259013 Boyden et al. Sep 2017 A1
20170265840 Bharat et al. Sep 2017 A1
20170303894 Scully Oct 2017 A1
20170367678 Sirtori et al. Dec 2017 A1
20180015256 Southard et al. Jan 2018 A1
20180116723 Hettrick et al. May 2018 A1
20180125450 Blackbourne May 2018 A1
20180161502 Nanan et al. Jun 2018 A1
20180199914 Ramachandran et al. Jul 2018 A1
20180214119 Mehrmohammadi et al. Aug 2018 A1
20180225993 Buras et al. Aug 2018 A1
20180228465 Southard et al. Aug 2018 A1
20180235576 Brannan Aug 2018 A1
20180250078 Shochat et al. Sep 2018 A1
20180272108 Padilla et al. Sep 2018 A1
20180279996 Cox et al. Oct 2018 A1
20180286287 Razzaque Oct 2018 A1
20180310955 Lindekugel et al. Nov 2018 A1
20180317881 Astigarraga et al. Nov 2018 A1
20180366035 Dunbar et al. Dec 2018 A1
20190060014 Hazelton Feb 2019 A1
20190069923 Wang Mar 2019 A1
20190076121 Southard et al. Mar 2019 A1
20190088019 Prevrhal et al. Mar 2019 A1
20190105017 Hastings Apr 2019 A1
20190117190 Djajadiningrat et al. Apr 2019 A1
20190223757 Durfee Jul 2019 A1
20190239850 Dalvin et al. Aug 2019 A1
20190282324 Freeman et al. Sep 2019 A1
20190298457 Bharat Oct 2019 A1
20190307516 Schotzko et al. Oct 2019 A1
20190339525 Yanof et al. Nov 2019 A1
20190355278 Sainsbury et al. Nov 2019 A1
20190365348 Toume et al. Dec 2019 A1
20200041261 Bernstein et al. Feb 2020 A1
20200069285 Annangi et al. Mar 2020 A1
20200113540 Gijsbers et al. Apr 2020 A1
20200129136 Harding et al. Apr 2020 A1
20200188028 Feiner et al. Jun 2020 A1
20200230391 Burkholz et al. Jul 2020 A1
20210007710 Douglas Jan 2021 A1
20210166583 Buras et al. Jun 2021 A1
20210307838 Xia et al. Oct 2021 A1
20210353255 Schneider et al. Nov 2021 A1
20210402144 Messerly Dec 2021 A1
20220022969 Misener Jan 2022 A1
20220039685 Misener et al. Feb 2022 A1
20220039777 Durfee Feb 2022 A1
20220096797 Prince Mar 2022 A1
20220104886 Blanchard et al. Apr 2022 A1
20220117582 McLaughlin et al. Apr 2022 A1
20220160434 Messerly et al. May 2022 A1
20220168050 Sowards et al. Jun 2022 A1
20220172354 Misener et al. Jun 2022 A1
20220211442 McLaughlin et al. Jul 2022 A1
20220381630 Sowards et al. Dec 2022 A1
20230113291 de Wild Apr 2023 A1
20230240643 Cermak Aug 2023 A1
20240008929 Misener et al. Jan 2024 A1
20240050061 McLaughlin et al. Feb 2024 A1
20240058074 Misener Feb 2024 A1
20240062678 Sowards et al. Feb 2024 A1
Foreign Referenced Citations (37)
Number Date Country
2006201646 Nov 2006 AU
114129137 Sep 2022 CN
0933063 Aug 1999 EP
1504713 Feb 2005 EP
1591074 May 2008 EP
3181083 Jun 2017 EP
3530221 Aug 2019 EP
2000271136 Oct 2000 JP
2014150928 Aug 2014 JP
2018175547 Nov 2018 JP
20180070878 Jun 2018 KR
20190013133 Feb 2019 KR
2013059714 Apr 2013 WO
2014115150 Jul 2014 WO
2014174305 Oct 2014 WO
2015017270 Feb 2015 WO
2017096487 Jun 2017 WO
2017214428 Dec 2017 WO
2018026878 Feb 2018 WO
2018134726 Jul 2018 WO
2018206473 Nov 2018 WO
2019232451 Dec 2019 WO
2020002620 Jan 2020 WO
2020016018 Jan 2020 WO
2019232454 Feb 2020 WO
2020044769 Mar 2020 WO
2020102665 May 2020 WO
2020186198 Sep 2020 WO
2022031762 Feb 2022 WO
2022072727 Apr 2022 WO
2022081904 Apr 2022 WO
2022-203713 Sep 2022 WO
2022263763 Dec 2022 WO
2023235435 Dec 2023 WO
2024010940 Jan 2024 WO
2024039608 Feb 2024 WO
2024039719 Feb 2024 WO
Non-Patent Literature Citations (51)
Entry
eZono, eZSimulator, https://www.ezono.com/en/ezsimulator/, last accessed Sep. 13, 2022.
Sonosim, https://sonosim.com/ultrasound-simulation/? last accessed Sep. 13, 2022.
U.S. Appl. No. 17/397,486, filed Aug. 9, 2021 Restriction Requirement dated Aug. 12, 2022.
Ikhsan Mohammad et al: “Assistive technology for ultrasound-guided central venous catheter placement”, Journal of Medical Ultrasonics, Japan Society of Ultrasonics in Medicine, Tokyo, JP, vol. 45, No. 1, Apr. 19, 2017, pp. 41-57, XPO36387340, ISSN: 1346-4523, DOI: 10.1007/S10396-017-0789-2 [retrieved on Apr. 19, 2017].
Lu Zhenyu et al “Recent advances in 5 robot-assisted echography combining perception control and cognition.” Cognitive Computation and Systems the Institution of Engineering and Technology, Michael Faraday House, Six Hills Way, Stevenage Herts. SG1 2AY UK vol. 2 No. 3 Sep. 2, 2020 (Sep. 2, 2020).
Pagoulatos, N. et al. “New spatial localizer based on fiber optics with applications in 3D ultrasound imaging” Proceeding of Spie, vol. 3976 (Apr. 18, 2000; Apr. 18, 2000).
PCT/US2021/042369 filed Jul. 20, 2021 International Search Report and Written Opinion dated Oct. 25, 2021.
PCT/US2021/044419 filed Aug. 3, 2021 International Search Report and Written Opinion dated Nov. 19, 2021.
PCT/US2021/045218 filed Aug. 9, 2021 International Search Report and Written Opinion dated Nov. 23, 2021.
PCT/US2021/053018 filed Sep. 30, 2021 International Search Report and Written Opinion dated May 3, 2022.
PCT/US2021/055076 filed Oct. 14, 2021 International Search Report and Written Opinion dated Mar. 25, 2022.
Sebastian Vogt: “Real-Time Augmented Reality for Image-Guided Interventions”, Oct. 5, 2009, XPO55354720, Retrieved from the Internet: URL: https://opus4.kobv.de/opus4-fau/frontdoor/deliver/index/docId/1235/file/SebastianVogtDissertation.pdf.
William F Garrett et al: “Real-time incremental visualization of dynamic ultrasound volumes using parallel BSP trees”, Visualization '96. Proceedings, IEEE, NE, Oct. 27, 1996, pp. 235-ff, XPO58399771, ISBN: 978-0-89791-864-0 abstract, figures 1-7, pp. 236-240.
U.S. Appl. No. 17/380,767, filed Jul. 20, 2021 Non-Final Office Action dated Mar. 6, 2023.
U.S. Appl. No. 17/393,283, filed Aug. 3, 2021 Non-Final Office Action dated Mar. 31, 2023.
U.S. Appl. No. 17/491,308, filed Sep. 30, 2021 Restriction Requirement dated Feb. 27, 2023.
PCT/US2021/050973 filed Sep. 17, 2021 International Search Report and Written Opinion dated Nov. 7, 2022.
U.S. Appl. No. 17/380,767, filed Jul. 20, 2021 Restriction Requirement dated Dec. 15, 2022.
U.S. Appl. No. 17/393,283, filed Aug. 3, 2021 Restriction Requirement dated Jan. 12, 2023.
U.S. Appl. No. 17/397,486, filed Aug. 9, 2021 Non-Final Office Action dated Jan. 23, 2023.
U.S. Appl. No. 17/501,909, filed Oct. 14, 2021 Restriction Requirement dated Feb. 1, 2023.
PCT/US2023/024067 filed May 31, 2023 International Search Report and Written Opinion dated Sep. 15, 2023.
PCT/US2023/027147 filed Jul. 7, 2023 International Search Report and Written Opinion dated Oct. 2, 2023.
State, A., et al. (Aug. 1996). Technologies for augmented reality systems: Realizing ultrasound-guided needle biopsies. In Proceedings of the 23rd annual conference on computer graphics and interactive techniques (pp. 439-446) (Year: 1996).
Stolka, P.J., et al., (2014). Needle Guidance Using Handheld Stereo Vision and Projection for Ultrasound-Based Interventions. In: Galland, P., Hata, N., Barillot, C., Hornegger, J., Howe, R. (eds) Medical Image Computing and Computer-Assisted Intervention—MICCAI 2014. MICCAI 2014. (Year: 2014).
U.S. Appl. No. 17/380,767, filed Jul. 20, 2021 Notice of Allowance dated Aug. 31, 2023.
U.S. Appl. No. 17/393,283, filed Aug. 3, 2021 Final Office Action dated Oct. 16, 2023.
U.S. Appl. No. 17/397,486, filed Aug. 9, 2021 Advisory Action dated Oct. 5, 2023.
U.S. Appl. No. 17/397,486, filed Aug. 9, 2021 Final Office Action dated Aug. 4, 2023.
U.S. Appl. No. 17/491,308, filed Sep. 30, 2021 Board Decison dated Oct. 25, 2023.
U.S. Appl. No. 17/491,308, filed Sep. 30, 2021 Final Office Action dated Aug. 29, 2023.
U.S. Appl. No. 17/491,308, filed Sep. 30, 2021 Non-Final Office Action dated Jun. 5, 2023.
U.S. Appl. No. 17/501,909, filed Oct. 14, 2021 Non-Final Office Action dated Jun. 6, 2023.
U.S. Appl. No. 17/861,031, filed Jul. 8, 2022 Non-Final Office Action dated Sep. 14, 2023.
PCT/US2023/030347 filed Aug. 16, 2023 International Search Report and Written Opinion dated Nov. 6, 2023.
U.S. Appl. No. 17/393,283, filed Aug. 3, 2021 Advisory Action dated Jan. 19, 2024.
U.S. Appl. No. 17/478,754, filed Sep. 17, 2021 Restriction Requirement dated Jan. 22, 2024.
U.S. Appl. No. 17/501,909, filed Oct. 14, 2021 Advisory Action dated Jan. 24, 2024.
U.S. Appl. No. 17/501,909, filed Oct. 14, 2021 Final Office Action dated Nov. 21, 2023.
PCT/US2023/030160 filed Aug. 14, 2023 International Search Report and Written Opinion dated Oct. 23, 2023.
Practical guide for safe central venous catheterization and management 2017 Journal of Anesthesia vol. 34 published online Nov. 30, 2019 pp. 167-186.
U.S. Appl. No. 17/393,283, filed Aug. 3, 2021 Non-Final Office Action dated Feb. 29, 2024.
U.S. Appl. No. 17/397,486, filed Aug. 9, 2021 Non-Final Office Action dated Mar. 1, 2024.
U.S. Appl. No. 17/491,308, filed Sep. 30, 2021 Non-Final Office Action dated Mar. 22, 2024.
U.S. Appl. No. 17/501,909, filed Oct. 14, 2021 Non-Final Office Action dated Mar. 21, 2024.
U.S. Appl. No. 17/861,031, filed Jul. 8, 2022 Final Office Action dated Mar. 15, 2024.
U.S. Appl. No. 17/397,486, filed Aug. 9, 2021 Notice of Allowance dated Jul. 10, 2024.
U.S. Appl. No. 17/478,754, filed Sep. 17, 2021 Non-Final Office Action dated Jul. 1, 2024.
U.S. Appl. No. 17/491,308, filed Sep. 30, 2021 Notice of Allowance dated Jun. 27, 2024.
U.S. Appl. No. 17/861,031, filed Jul. 8, 2022 Advisory Action dated Jun. 7, 2024.
U.S. Appl. No. 17/861,031, filed Jul. 8, 2022 Notice of Allowance dated Jul. 3, 2024.
Related Publications (1)
Number Date Country
20230389893 A1 Dec 2023 US